Advertisement
The Medicine Maker / Issues / 2026 / February / Electronic Lab Notebooks Are Failing Scientists and Inflating RD Costs
Business & Regulation Future of Pharma Industry News

Electronic Lab Notebooks Are Failing Scientists and Inflating R&D Costs

New survey finds outdated lab software is driving experiment duplication, workflow bottlenecks, and risky shadow AI use

02/10/2026 2 min read News

Share

Advertisement

Recommended

Advertisement

Related Content

Novartis and BMS Pause Autoimmune CAR T Trials Over Safety Concerns
Cell & Gene Industry News
Novartis and BMS Pause Autoimmune CAR T Trials Over Safety Concerns

September 16, 2026

2 min read

Three deaths linked to immune effector cell-associated hemophagocytic syndrome prompt Novartis to halt eight rap-cel studies

Personalized Cancer Vaccine Linked to Three-Year Disease-Free Survival in Head and Neck Cancer
Industry News Research News Cell & Gene
Personalized Cancer Vaccine Linked to Three-Year Disease-Free Survival in Head and Neck Cancer

September 16, 2026

2 min read

All 16 patients who received TG4050 after standard treatment remained disease-free, compared with 13 of 16 patients in the control group

What Do Scientists Want from AI?
Future of Pharma Regulation & Standards
What Do Scientists Want from AI?

September 14, 2026

5 min read

Scientists are already using AI in the lab – but many are doing so without the safeguards their employers may assume are in place

What Will Drug Development Look Like in 2036?
Future of Pharma Future of Pharma Business & Trends
What Will Drug Development Look Like in 2036?

September 3, 2026

7 min read

Members of The Medicine Maker’s 2026 Power List predict how AI, new modalities, integrated data, and shifting global markets will reshape the industry

Advertisement